Acquired perforating dermatosis associated with risankizumab

JAAD Case Rep. 2024 Feb 2:45:88-90. doi: 10.1016/j.jdcr.2024.01.023. eCollection 2024 Mar.

Authors

Munira Alhadlg¹, Ghadah Alhammad¹, Abdulaziz Madani¹

Affiliation

¹ Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

No abstract available

Keywords: acquired perforating dermatosis; interleukin-23 inhibitor; risankizumab.

Publication types

Case Reports